Cooperative pro-tumorigenic adaptation to oncogenic RAS through epithelial-to-mesenchymal plasticity - CRCL-Gastroentérologie et technologies pour la santé
Journal Articles Science Advances Year : 2024

Cooperative pro-tumorigenic adaptation to oncogenic RAS through epithelial-to-mesenchymal plasticity

Frédérique Fauvet
Roxane Pommier
Christelle Lamblot
Rahma Benhassoun
Francesca Angileri
Anne-Pierre Morel

Abstract

In breast cancers, aberrant activation of the RAS/MAPK pathway is strongly associated with mesenchymal features and stemness traits, suggesting an interplay between this mitogenic signaling pathway and epithelial-tomesenchymal plasticity (EMP). By using inducible models of human mammary epithelial cells, we demonstrate herein that the oncogenic activation of RAS promotes ZEB1-dependent EMP, which is necessary for malignant transformation. Notably, EMP is triggered by the secretion of pro-inflammatory cytokines from neighboring RASactivated senescent cells, with a prominent role for IL-6 and IL-1α. Our data contrast with the common view of cellular senescence as a tumor-suppressive mechanism and EMP as a process promoting late stages of tumor progression in response to signals from the tumor microenvironment. We highlighted here a pro-tumorigenic cooperation of RAS-activated mammary epithelial cells, which leverages on oncogene-induced senescence and EMP to trigger cellular reprogramming and malignant transformation.
Fichier principal
Vignette du fichier
sciadv.adi1736.pdf (3.01 Mo) Télécharger le fichier
Origin Publisher files allowed on an open archive
licence

Dates and versions

hal-04459389 , version 1 (15-02-2024)

Licence

Identifiers

Cite

Hadrien de Blander, Laurie Tonon, Frédérique Fauvet, Roxane Pommier, Christelle Lamblot, et al.. Cooperative pro-tumorigenic adaptation to oncogenic RAS through epithelial-to-mesenchymal plasticity. Science Advances , 2024, 10 (7), ⟨10.1126/sciadv.adi1736⟩. ⟨hal-04459389⟩
347 View
74 Download

Altmetric

Share

More